Lipemia: Causes, interference mechanisms, detection and management

Biochemia Medica

Volumn 24, Issue 1, 2014, Pages 57-67

  Nikolac, Nora ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Biological variation; Interference testing; Laboratory error; Lipemia interference; Preanalytical phase

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; CHYLOMICRON; GAMMA GLUTAMYLTRANSFERASE; INTRALIPID; IVELIP; LIPID EMULSION; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANALYTICAL ERROR; BLOOD SAMPLING; CENTRIFUGATION; EXTRACTION; FALSE POSITIVE RESULT; HUMAN; HYPERLIPIDEMIA; PARENTERAL NUTRITION; PATIENT SAFETY; PROTHROMBIN TIME; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VISION;

BIOLOGICAL VARIATION; INTERFERENCE TESTING; LABORATORY ERROR; LIPEMIA INTERFERENCE; PREANALYTICAL PHASE;

BLOOD CHEMICAL ANALYSIS; DIAGNOSTIC ERRORS; HEMOLYSIS; HUMANS; HYPERLIPIDEMIAS; LIPIDS;

EID: 84893618127     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/BM.2014.008     Document Type: Review

References (59)

1. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
2. Lippi G, Becan-McBride K, Behúlová D, Bowen RAR, Church S, Delanghe JR, et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med 2013;51:229-41. http://dx.doi.org/10.1515/cclm-2012-0597.
3. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764-72. http://dx.doi.org/10.1515/CCLM.2008.170.
4. Glick MR, Ryder KW, Glick SJ, Woods JR. Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. Clin Chem 1989;35:837-9.
5. Simundic AM, Nikolac N, Vukasovic I, Vrkic N. The prevalence of preanalytical errors in Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med 2010;48:1009-14. http://dx.doi.org/10.1515/CCLM.2010.221.
6. Goswami B, Singh B, Chawla R, Mallika V. Evaluation of errors in a clinical laboratory: a one-year experience. Clin Chem Lab Med 2010;48:63-6. http://dx.doi.org/10.1515/CCLM.2010.006.
7. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113-26. http://dx.doi.org/10.1515/CCLM.2011.600.
8. Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop? Semin Thromb Hemost 2012;38:553-8. http://dx.doi.org/10.1055/s-0032-1315960.
9. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003;52:453-62. http://dx.doi.org/10.2337/diabetes.52.2.453.
10. Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost 2013;39:258-66.
11. Kackov S, Simundic AM, Gatti-Drnic A. Are patients well informed about the fasting requirements for laboratory blood testing? Biochem Med 2013;23:326-31. http://dx.doi.org/10.11613/BM.2013.040.
12. Nikolac N, Šupak-Smolčič V, Šimundić AM, Ćelap I. Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling. Biochem Med 2013;23:242-54. http://dx.doi.org/10.11613/BM.2013.031.
13. Povjerenstvo za stručna pitanja Hrvatske komore medicinskih biokemičara. [Standardi dobre stručne prakse]. (in Croatian). Available at: http://www.hkmb.hr/povjerenstva/strucna-pitanja.html#1. Accessed October 19, 2013.
14. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M. Standardisation of collection requirements for fasting samples. Clin Chim Acta 2013; in press. http://dx.doi.org/10.1016/j.cca.2013.11.008.
15. Lim KH, Lian WB, Yeo CL. Does visual turbidity correlate with serum triglyceride levels in babies on total parenteral nutrition? Ann Acad Med Singapore 2006;35:790-3.
16. Ren T, Cong L, Wang Y, Tang Y, Tian B, Lin X, et al. Lipid emulsions in parenteral nutrition: current applications and future developments. Expert Opin Drug Deliv 2013;10:1533-49. http://dx.doi.org/10.1517/17425247.2013.824874.
17. Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol (Phila) 2013;51:896-8. http://dx.doi.org/10.3109/15563650.2013.831436.
18. Bartos M, Knudsen K. Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine. Clin Toxicol (Phila) 2013;51:501-4. http://dx.doi.org/10.3109/15563650.2013.803229.
19. Intralipid. Available at: http://www.drugs.com/pro/intralipid.html. Accessed October 22, 2013.
20. Bossuyt X, Schiettekatte G, Bogaerts A, Blanckaert N. Serum protein electrophoresis by CZE 2000 clinical capillary electrophoresis system. Clin Chem 1998;44:749-59.
21. Schiettecatte J, Anckaert E, Smitz J. Interferences in Immunoassays. In: Advances in Immunoassay Technology, Chiu NHL (Ed.), InTech, 2012. Available at: http://www.intechopen.com/books/advances-in-immunoassay-technology/interference-in-immunoassays. Accessed October 10, 2013.
22. Kroll MH, McCudden CR. Endogenous Interferences in Clinical Laboratory Tests. Icteric, Lipemic and Turbid Samples. Berlin, Boston: De Gruyter, 2012. http://dx.doi.org/10.1515/9783110266221.
23. Kroll MH. Evaluating interference caused by lipemia. Clin Chem 2004;50:1968-9. http://dx.doi.org/10.1373/clinchem.2004.038075.
24. Nikolac N, Simundic AM, Miksa M, Lima-Oliveira G, Salvagno GL, Caruso B, Guidi GC. Heterogeneity of manufacturers' declarations for lipemia interference urgent call for standardization. Clin Chim Acta 2013;426:33-40. http://dx.doi.org/10.1016/j.cca.2013.08.015.
25. de Cordova CM, Nogara MS, de Cordova MM. Interference on the laboratory measurement of bilirubin: the effect of in vitro interactions. Clin Chim Acta 2009;407:77-9. http://dx.doi.org/10.1016/j.cca.2009.06.037.
26. Gobert De Paepe E, Munteanu G, Schischmanoff PO, Porquet D. Haemolysis and turbidity influence on three analysis methods of quantitative determination of total and conjugated bilirubin on ADVIA 1650. (in French). Ann Biol Clin (Paris) 2008;66:175-82.
27. Meany D, Schowinsky J, Clarke W. Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. Clin Biochem 2008;41:1486-8. http://dx.doi.org/10.1016/j.clinbiochem.2008.09.111
28. Volume Displacement of Electrolytes by Lipemia. Available at: https://ahdc.vet.cornell.edu/clinpath/modules/chem/volume.htm. Accessed December 2nd, 2013.
29. Lyon AW, Baskin LB. Pseudohyponatremia in a Myeloma Patient: Direct Electrode Potentiometry is a Method Worth its Salt. LabMedicine 2003;34:357-60.
30. Fortgens P, Pillay TS. Pseudohyponatremia revisited: a modern-day pitfall. Arch Pathol Lab Med 2011;135:516-9.
31. Kim GH. Pseudohyponatremia: Does It Matter in Current Clinical Practice? Electrolyte & Blood Pressure 2006;4:77-82. http://dx.doi.org/10.5049/EBP.2006.4.2.77.
32. Kazmierczak SC. Hemolysis, Lipemia, and High Bilirubin: Effect on Laboratory Tests. In: Dasgupta A, Sepulveda JL, eds. Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction. Amsterdam: Elsevier 2013; p. 53-62. http://dx.doi.org/10.1016/B978-0-12-415783-5.00005-0.
33. Salvagno GL, Lippi G, Gelati M, Guidi GC. Hemolysis, lipaemia and icterus in specimens for arterial blood gas analysis. Clin Biochem 2012;45:372-3. http://dx.doi.org/10.1016/j.clinbiochem.2011.12.005
34. Simundic AM, Nikolac N, Ivankovic V, Ferenec-Ruzic D, Magdic B, Kvaternik M, Topic E. Comparison of visual versus automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361-5. http://dx.doi.org/10.1515/CCLM.2009.306.
35. Twomey PJ, Don-Wauchope AC, McCullough D. Unreliability of triglyceride measurement to predict turbidity induced interference. J Clin Pathol 2003;56:861-2. http://dx.doi.org/10.1136/jcp.56.11.861.
36. Speeckaert MM, Segers H, Biesen WV, Verstraete A, Langlois MR, Delanghe JR. An unusual case of (pseudo)hypertriglyceridaemia. NDT Plus 2010;3:570-2. http://dx.doi.org/10.1093/ndtplus/sfq148.
37. Hellerud C, Burlina A, Gabelli C, Ellis JR, Nyholm PG, Lindstedt S. Glycerol metabolism and the determination of triglycerides--clinical, biochemical and molecular findings in six subjects. Clin Chem Lab Med 2003;41:46-55. http://dx.doi.org/10.1515/CCLM.2003.009.
38. De Haene H, Taes Y, Christophe A, Delanghe J. Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism. Clin Chem Lab Med 2006;44:220-2. http://dx.doi.org/10.1515/CCLM.2006.040.
39. Fliser E, Jerkovic K, Vidovic T, Gorenjak M. Investigation of unusual high serum indices for lipemia in clear serum samples on Siemens analysers Dimension. Biochem Med 2012;22:352-62. http://dx.doi.org/10.11613/BM.2012.037.
40. Munnix ICA, Raijmakers MTM, Oosterhuis WP, Kleinveld HA. Detection of a monoclonal gammopathy by lipemiaindex measurement. Ned Tijdschr Klin Chem Labgeneesk 2009;34:248-9.
41. Darby D, Broomhead C. Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V. Ann Clin Biochem 2008;45:289-92. http://dx.doi.org/10.1258/acb.2007.007176.
42. Clinical Laboratory Standards Institute. Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline. CLSI C56-A document. Clinical Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2012.
43. Calmarza P, Cordero J. Lipemia interferences in routine clinical biochemical tests. Biochem Med 2011;21:160-6. http://dx.doi.org/10.11613/BM.2011.025.
44. Dimeski G, Jones BW. Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation. Biochem Med 2011;21:86-92. http://dx.doi.org/10.11613/BM.2011.016.
45. Sharma A, Anderson K, Baker JW. Flocculation of serum lipoproteins with cyclodextrins: application to assay of hyperlipidemic serum. Clin Chem 1990;36:529-32.
46. Lipoclear. Available at: http://www.statspin.com/pdfs/64-003957-001D.pdf. Accessed October 27, 2013.
47. Thibeault J. Various Analytes Tested Before and After Treatment with LipoClear®, StatSpin's Lipemic Clearing Agent. Available at: http://www.statspin.com/pdfs/64-005075-001.pdf. Accessed October 27, 2013.
48. Vermeer HJ, Steen G, Naus AJ, Goevaerts B, Agricola PT, Schoenmakers CH. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach. Clin Chem Lab Med 2007;45:114-9. http://dx.doi.org/10.1515/CCLM.2007.004.
49. Saracevic A, Nikolac N, Simundic AM. The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipemia removal. Clin Biochem 2014;pii:S0009-9120(14)00004-6.
50. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986;32:470-5.
51. Clinical Laboratory Standards Institute. Interference Testing in Clinical Chemistry; Approved Guideline, Second Edition. CLSI document EP7-A2. Clinical Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2005.
52. Nanji AA, Poon R, Hinberg I. Lipaemic interference: effects of lipaemic serum and intralipid. J Clin Pathol 1988;41:1026-7. http://dx.doi.org/10.1136/jcp.41.9.1026.
53. Bornhorst JA, Roberts RF, Roberts WL. Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. Clin Chem 2004;50:2197-201. http://dx.doi.org/10.1373/clinchem.2004.040154.
54. Ricos C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500. This database was most recently updated in 2012. Available at: http://www.westgard.com/biodatabase1.htm. Accessed October 27, 2013.
55. Westgard JO, Carey RN, Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem USA 1974;20:825-33.
56. Steen G, Vermeer HJ, Naus AJ, Goevaerts B, Agricola PT, Schoenmakers CH. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays. Clin Chem Lab Med 2006;44:413-9. http://dx.doi.org/10.1515/CCLM.2006.067.
57. Grunbaum AM, Gilfix BM, Gosselin S, Blank DW. Analytical interferences resulting from intravenous lipid emulsion. Clin Toxicol (Phila) 2012;50:812-7. http://dx.doi.org/10.3109/15563650.2012.731509.
58. Ji JZ, Meng QH. Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays. Clin Chim Acta 2011;412:1550-3. http://dx.doi.org/10.1016/j.cca.2011.04.034.
59. Szoke D, Braga F, Valente C, Panteghini M. Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays. Clin Chim Acta 2012;413:339-41; author reply 342-3. http://dx.doi.org/10.1016/j.cca.2011.09.044.